ANGPTL3 and metabolic syndrome: Contemporary RNA-based antisense oligonucleotides and small interfering RNA’s for apoC3 and the angiopoietin-like 3 (ANGPTL3) profoundly attenuate plasma triglyceride in familial chylomicronemia, severe hypertriglyceridemia, dyslipidemia and T2DM (54).